[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@phsiao4 "-2 Emicizumab (Hemlibra) Faricimab (Vabysmo) Zanidatamab (Ziihera) Zenocutuzumab (Bizengri) Linvoseltamab (Lynozyfic)"
X Link @phsiao4 2025-10-09T23:35Z XXX followers, XX engagements

"Passionflower is a rapidly growing trailing or climbing perennial or herbaceous perennial. It is a member of the passion vine family (Passifloraceae). It is native to the southeastern and south-central parts of the United States as well as Bermuda"
X Link @phsiao4 2025-10-13T00:40Z XXX followers, XXX engagements

"A gorgeous day (after the first Pacific storm)"
X Link @phsiao4 2025-10-15T01:07Z XXX followers, XX engagements

"University of Minnesota Health Sciences Education Center"
X Link @phsiao4 2025-10-15T17:38Z XXX followers, XXX engagements

"Pharmacy Demand Report: Highlights for pharmacist job postings for third quarter of 2025: California had the highest number of job postings (2641) followed by Texas (2080) Florida (1500) New York (1083) and Ohio (1052)"
X Link @phsiao4 2025-10-14T00:16Z XXX followers, XX engagements

"Tarlatamab (Imdellra): Developed by Amgen tarlatamab is a BiTE molecule targeting DLL3 and CD3. It is used for the treatment of small cell lung cancer (SCLC). Approved in 2024"
X Link @phsiao4 2025-10-09T23:38Z XXX followers, XXX engagements